- TheStreet.com•8 hours ago
The FTC went beyond the traditional focus on head-to-head competition and considered three new theories of competitive harm.
- TheStreet.com•13 hours ago
It took 12 months for Teva to gain FTC approval to buy Allergan's U.S. generics business. Future mergers could face the same long scrutiny.
- Motley Fool•13 hours ago
Prominent money managers cut their stakes in some high-profile stocks in the second quarter -- but was it a smart move?
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||51.48 x 100|
|Ask||51.67 x 100|
|Day's Range||51.14 - 51.98|
|52wk Range||48.01 - 66.55|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||34.44|
|Avg Vol (3m)||5,744,646|
|Dividend & Yield||1.36 (2.63%)|